Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 11 of the 44 sources its claims cite were checked for support.
Abstract
Limb-girdle muscular dystrophy type 2H (LGMD2H) is a mild autosomal recessive myopathy that was first described in the Manitoba Hutterite population. Previous studies in our laboratory mapped the causative gene for this disease to a 6.5-Mb region in chromosomal region 9q31-33, flanked by D9S302 and D9S1850. We have now used additional families and a panel of 26 microsatellite markers to construct haplotypes. Twelve recombination events that reduced the size of the candidate region to 560 kb were identified or inferred. This region is flanked by D9S1126 and D9S737 and contains at least four genes. Exons of these genes were sequenced in one affected individual, and four sequence variations were identified. The families included in our study and 100 control individuals were tested for these variations. On the basis of our results, the mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H. All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls. This mutation occurs in an NHL (named after the proteins NCL1, HT2A, and LIN-41) domain at a position that is highly conserved. NHL domains are known to be involved in protein-protein interactions. Although the function of TRIM32 is unknown, current knowledge of the domain structure of this protein suggests that it may be an E3-ubiquitin ligase. If proven, this represents a new pathogenic mechanism leading to muscular dystrophy.
Overview
CoChat Summary
## TL;DR
The paper fine-maps the autosomal recessive LGMD2H locus in Manitoba Hutterite families from a 6.5 Mb interval to 560 kb and identifies TRIM32 D487N as the most likely disease-causing mutation. The authors propose that TRIM32 may function as an E3 ubiquitin ligase, suggesting a novel ubiquitin-proteasome mechanism for muscular dystrophy.
## Key findings
- Haplotype analysis in six interrelated Hutterite families identified 12 recombination events that reduced the LGMD2H candidate region from 6.5 Mb to 560 kb, flanked by D9S1126 and D9S737.
- Sequencing of the genes in this interval found four sequence variations; the best candidate was TRIM32 c.1459G>A (p.D487N).
- The paper reports that all 35 affected individuals with LGMD2H were homozygous for V4(Asn)/D487N, and the mutation was not observed in 100 controls.
- The altered residue lies in the third NHL domain of TRIM32 and is one of the two most highly conserved positions in that domain; the authors also state that TRIM32 shows two transcript sizes, 3.3 and 2.5 kb, and is expressed in skeletal muscle.
## Methods
- Studied 35 clinically affected Hutterite patients and their immediate families; genotypes were obtained for 117 individuals across six interrelated families, with 100 controls used for comparison.
- Performed haplotype analysis using 22 additional microsatellite markers to refine the disease interval, then used SSCA, DNA sequencing, and PCR/restriction assays to screen candidate genes and sequence variants.
- Assessed TRIM32 expression with a 12-tissue northern blot and used RT-PCR on RNA from cultured skin fibroblasts to examine whether the PAPPA silent variant affected splicing.
## Limitations
- The paper explicitly notes that the information they possessed did not exclude the possibility that V3 may contribute additional effects to the phenotype.
- They also state that they cannot exclude the possibility that V3 affects an exonic splicing enhancer active only in muscle or mRNA secondary structure; this is a stated uncertainty.
- Evident from the text: the causal claim is based on genetic segregation, absence in controls, and domain conservation, but the paper does not provide functional proof that TRIM32 D487N alters ubiquitin-ligase activity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 19 Not checked · 55 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“TRIM32 has, from N- to C-terminal ends, a RINGfinger domain, a B1 box, a coiled-coil domain, and six NHLdomains”
What the sources say
- Could not verifycites Apweiler et al. 2001 sourceExperimental — accuracy not yet measured
The Integration Methods section (p. 2) explains how InterPro describes domains in multidomain proteins, but it does not describe TRIM32. Searches for TRIM32, RING finger, B1 box, coiled-coil, and NHL domains found no passage establishing the claimed domains, their order, or the count of six. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The V3(T) allele was found to have a frequency of 2% in controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three recombination events were identified in individuals C-06, C-07, and E-11, thereby reducing the candidate region from 6.5 Mb to an interval of 713 kb flanked by D9S241 and D9S931 (fig. 1).”
plainstates a causen = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SSCA of exons located between the flanking microsatellitemarkers D9S1126 and D9S737 revealed only one silent substitution (i.e., V3) in PAPPA.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 40
- It may state two separate claims as one. 25
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Subjects and Methods
“Table 1 Four Sequence Variations Found in Exons within the LGMD2H Candidate Region”
§ Mutation Screening
“V1, an 11-bp deletion in intron 2 of PAPPA, can be excluded as the disease-causing mutation, because it does not segregate with LGMD2H and is outside the candidate region as defined by an inferred ancestral recombination event (in individual E-23; fig. 2).”
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Parkin, the product of PARK2, is known to be a RINGfinger–containing E3-Ub ligase (Shimura et al. 2000).”
BackgroundThe tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366 · cited 3×
“It was originally discovered using a yeast two-hybrid assay with the human immunodeficiency virus type 1 Tat acting as bait (Fridell et al. 1995; Reymond et al. 2001).”
BackgroundMethodJoazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 2×
“It has been shown that the RINGfinger domain of an E3 ligase mediates interaction with the E2-conjugating enzyme and is the source of the ligase activity (Joazeiro and Weissman 2000).”
BackgroundApweiler, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.37 · Cited by 1,079
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Slack, F. J., Basson, M., Liu, Z., Ambros, V., Horvitz, H. R., & Ruvkun, G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80245-2 · Cited by 751
Cited by
Items 101–200 of 261
The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy
Schmidt, F., Kny, M., Zhu, X., Wollersheim, T., Persicke, K., Langhans, C., Lodka, D., Kleber, C., Weber-Carstens, S., & Fielitz, J. (2014) · Critical Care · doi:10.1186/s13054-014-0545-6 · Cited by 42
“For instance, mutated TRIM32 leads to limb-girdle muscular dystrophy type 2H [27]; mutations in TRIM18 (MID1) cause Opitz G/BBB syndrome [28]; and TRIM63/MuRF1 mutations result in hypertrophic cardiomyopathy [29].”
BackgroundMolecular bases of autosomal recessive limb-girdle muscular dystrophies.
Nigro, V. (2003) · Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · Cited by 55
Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia
Quintás‐Cardama, A., Zhang, N., Qiu, Y. H., Post, S. M., Creighton, C. J., Cortes, J. E., Coombes, K. R., & Kornblau, S. M. (2014) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2014.07.011 · Cited by 44
Intragenic deletion ofTRIM32in compound heterozygotes with sarcotubular myopathy/LGMD2H
Borg, K., Stucka, R., Locke, M., Melin, E., hlberg, G. Ã., Klutzny, U., von der Hagen, M., Huebner, A., Lochmüller, H., Wrogemann, K., et al. (2009) · Human Mutation · doi:10.1002/humu.21063 · Cited by 45
Self-citationWagner, K. R. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00002-6 · Cited by 45
“A candidate mutation associated with the disease has recently been proposed in the tripartite-motif-containing gene 32 (TRIM32), encoding a putative E3-ubiquitin-ligase [66].”
BackgroundCalpain 3 Is a Rapid-Action, Unidirectional Proteolytic Switch Central to Muscle Remodeling
de Morrée, A., Hulsik, D. L., Impagliazzo, A., van Haagen, H. H. H. B. M., Galan, P., van Remoortere, A., Hoen, P. A. C. ’., van Ommen, G. B., Frants, R. R., & van der Maarel, S. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011940 · Cited by 39
“[36] Therefore PIAS regulation may connect two genetically distinct types of LGMD.”
BackgroundBalcı, B., Aurino, S., Haliloğlu, G., et al. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-005-0046-3 · Cited by 39
“At least 10 different genetic loci leading to LGMD2 are recognized: LGMD2A (calpain-3) [26], LGMD2B (dysferlin) [2, 16], LGMD2C (γ-sarcoglycan, γ-SG) ) [22], LGMD2D (α-sarcoglycan, α-SG) [30], LGMD2E (β-sarcoglycan, β-SG) [4, 15], LGMD2F (δsarcoglycan, δ-SG) [19], LGMD2G (telethonin) [18], LGMD2H (TRIM 32) [13], LGMD2…”
Deletion of TRIM32 protects mice from anxiety‐ and depression‐like behaviors under mild stress
Ruan, C., Wang, S., Shen, Y., Guo, Y., Yang, C., Zhou, F. H., Tan, L., Zhou, L., Liu, J., Wang, W., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12618 · Cited by 37
“ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; CUMS, chronic unpredictable mild stress; EOM, elevated zero maze test; FST, forced swimming test; LGMD2H, limb–girdle muscular dystrophy type 2H; OCD, obsessive compulsive disorder; OFT, open field test; SPT, sucrose preference test; SSRI,…”
BackgroundInfluentialIchimura, T., Taoka, M., Shoji, I., Kato, H., Sato, T. Z., Hatakeyama, S., Isobe, T., & Hachiya, N. (2013) · Journal of Cell Science · doi:10.1242/jcs.122069 · Cited by 40
“TRIM32 is ubiquitously expressed in mammalian tissues, but the level varies depending on cell type and conditions (Fridell et al., 1995; Frosk et al., 2002; Horn et al., 2004; Kano et al., 2008).”
BackgroundNon-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway
Zhao, M., Song, K., Hao, W., Wang, L., Patil, G., Li, Q., Xu, L., Hua, F., Fu, B., Schwamborn, J. C., et al. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz081 · Cited by 38
“Several mutations in the NHL repeats of TRIM32 have been found in the LGMD2H patients (Frosk et al., 2002; Saccone et al., 2008).”
BackgroundTRIM2, a novel member of the antiviral family, limits New World arenavirus entry
Sarute, N., Ibrahim, N., Fagla, B. M., Lavanya, M., Cuevas, C., Stavrou, S., Otkiran, G., Tyynismaa, H., Henao‐Mejia, J., & Ross, S. R. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000137 · Cited by 39
The ties that bind: functional clusters in limb-girdle muscular dystrophy
Barton, E. R., Pacak, C. A., Stoppel, W. L., & Kang, P. B. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-00240-7 · Cited by 38
“LGMD R8 (LGMD2H) TRIM32 [27] TRIM32 Myofibril [28] E3-ubiquitin-ligase”
Bawa, S., Piccirillo, R., & Geisbrecht, E. R. (2021) · Biomolecules · doi:10.3390/biom11030408 · Cited by 39
“D487N in the third NHL repeat was present in 41 Hutterite families with diagnosed LGMD2H [10,48,49].”
BackgroundHutterite brothers both affected with two forms of limb girdle muscular dystrophy: LGMD2H and LGMD2I
Frosk, P., Bigio, M. R. D., Wrogemann, K., & Greenberg, C. R. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201436 · Cited by 36
Self-citationHarel, T., Goldberg, Y., Shalev, S. A., Chervinsky, I., Ofir, R., & Birk, O. S. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201087 · Cited by 35
Altered myogenesis and premature senescence underlie human TRIM32-related myopathy
Servián‐Morilla, E., Cabrera‐Serrano, M., Rivas, E., Carvajal, A., Lamont, P. J., Pelayo‐Negro, A. L., Ravenscroft, G., Junckerstorff, R. C., Dyke, J. M., Fletcher, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0683-9 · Cited by 35
TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders
Meroni, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_14 · Cited by 34
Wulczyn, F. G., Cuevas, E., Franzoni, E., & Rybak‐Wolf, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7823-3_9 · Cited by 35
Fatima, M., Kumari, R., Schwamborn, J. C., Mahadevan, A., Shankar, S. K., Raja, R., & Seth, P. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.138 · Cited by 31
Cossée, M., Lagier‐Tourenne, C., Seguela, C., Mohr, M., Leturcq, F., Gündeşli, H., Chelly, J., Tranchant, C., Koenig, M., & Mandel, J. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.02.003 · Cited by 34
“TRIM32 additionally contains a C terminal domain constituted of six NHL-repeats, known to be involved in protein–protein interactions [5,19] and predicted to form a six-bladed b-propeller structure [2].”
BackgroundResultInfluentialEmerging Role of TRIM Family Proteins in Cardiovascular Disease
Zhang, J., Li, X., Hu, W., & Li, C. (2020) · Cardiology · doi:10.1159/000506150 · Cited by 32
Goyani, S., Roy, M., & Singh, R. K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166066 · Cited by 30
Further delineation of the clinical spectrum of de novo TRIM8 truncating mutations
Assoum, M., Lines, M. A., Elpeleg, O. N., Darmency, V., Whiting, S. E., Edvardson, S., Devinsky, O., Heinzen, E. L., Hernan, R., Antignac, C., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40357 · Cited by 31
“Mutations in TRIM32 were associated with autosomal recessive Limb-Girdle Muscular Dystrophy 2H (Frosk et al., 2002; Lazzari & Meroni, 2016).”
BackgroundOverå, K. S., Garcia‐Garcia, J., Bhujabal, Z., Jain, A., Øvervatn, A., Larsen, K. B., Deretic, V. P., Johansen, T., Lamark, T., & Sjøttem, E. (2019) · Journal of Cell Science · doi:10.1242/jcs.236596 · Cited by 30
Nectoux, J., de Cid, R., Baulande, S., Leturcq, F., Urtizberea, J. A., Pénisson-Besnier, I., Nadaj‐Pakleza, A., Roudaut, C., Criqui, A., Orhant, L., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.223 · Cited by 31
Pregnancy-associated plasma protein-A polymorphism and the risk of recurrent pregnancy loss
Suzuki, K., Sata, F., Yamada, H., Saijo, Y., Tsuruga, N., Minakami, H., & Kishi, R. (2006) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.11.004 · Cited by 27
“Recently, a missense A/C (Tyr/Ser) polymorphism (dbSNP: rs7020782) in exon 14 of the PAPPA gene was described (Frosk et al., 2002).”
BackgroundNeri, M., Selvatici, R., Scotton, C., Trabanelli, C., Armaroli, A., Grandis, D. D., Lévy, N., Gualandi, F., & Ferlini, A. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.02.003 · Cited by 26
Differential diagnosis of vacuolar myopathies in the NGS era
Mair, D., Biskup, S., Kreß, W., Abicht, A., Brück, W., Zechel, S., Knop, K. C., König, F. B., Tey, S., Nikolin, S., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12864 · Cited by 30
“All LGMD2H (LGMDR8) mutations reported so far are located within the NHL domain of TRIM32 which is critical for the recognition of protein targets for ubiquitination (27,53).”
BackgroundChildhood Onset of Limb-Girdle Muscular Dystrophy
Rosales, X. Q., & Tsao, C. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.08.014 · Cited by 26
“All of the limb-girdle muscular dystrophies are rare, and some were described in only a few families [11] or in ethnic minorities [12,13].”
BackgroundE3 ubiquitin ligases and their therapeutic potential in disease Management
Madhukar, G., Haque, M. A., Khan, S., Kim, J.-J., & Danishuddin (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116875 · Cited by 26
The genetic and molecular bases of monogenic disorders affecting proteolytic systems
Richard, I. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028118 · Cited by 23
Petrera, F., & Meroni, G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5398-7_10 · Cited by 27
How to go about diagnosing and managing the limb-girdle muscular dystrophies
Bushby, K. M. D., & Guglieri, M. (2008) · Neurology India · doi:10.4103/0028-3886.43445 · Cited by 28
“LGMD2H LGMD2H results from mutations in the TRIM32 gene and has been only recently described in non-Hutterite populations.[27-29]”
BackgroundRamachandran, H., Schäfer, T., Kim, Y., Herfurth, K., Hoff, S., Lienkamp, S. S., Kramer-Zucker, A. G., & Walz, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534024 · Cited by 23
“BBS11/TRIM32 contains six C-terminal NHL repeats, and a mutation located within the third NHL repeat (D487N) is associated with limb girdle muscular dystrophy type 2H, an autosomal recessive muscular disorder (28).”
BackgroundThe neural stem cell fate determinant TRIM32 regulates complex behavioral traits
Hillje, A., Beckmann, E., Pavlou, M. A. S., Jaeger, C., Pacheco, M. P., Sauter, T., Schwamborn, J. C., & Lewejohann, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00075 · Cited by 20
“TRIM32 has been linked to several human diseases including limb–girdle muscular dystrophy type 2H (Frosk et al., 2002, 2005; Kudryashova et al., 2005, 2012), Bardet–Biedl syndrome (Chiang et al., 2006), cancer (Horn et al., 2004; Kano et al., 2008), autism spectrum disorder (Lionel et al., 2011,…”
MethodDiagnostic immunohistochemistry in neuromuscular disorders
Tews, D. S., & Goebel, H. H. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02025.x · Cited by 20
“Mutations in the TRIM32 gene on chromosome 9, encoding a putative E3-ubiquitin ligase, have been linked to LGMD type 2H.(174) The impact of immunohistochemistry and Western blot analysis in the diagnosis of this protein defect, however, has still to be determined.”
BackgroundGreenberg, S. A., & Walsh, R. J. (2005) · Muscle & Nerve · doi:10.1002/mus.20279 · Cited by 19
The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy
Assereto, S., Piccirillo, R., Baratto, S., Scudieri, P., Fiorillo, C., Massacesi, M., Traverso, M., Galietta, L. J. V., Bruno, C., Minetti, C., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.63 · Cited by 24
Lazzari, E., El-Halawany, M. S., March, M. D., Valentino, F., Cantatore, F., Migliore, C., Onesti, S., & Meroni, G. (2019) · Cells · doi:10.3390/cells8030254 · Cited by 20
A recessive Trim2 mutation causes an axonal neuropathy in mice
Li, J. J., Sarute, N., Lancaster, E., Otkiran, G., Fagla, B. M., Ross, S. R., & Scherer, S. S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104845 · Cited by 19
“TRIM32 is thought to play a role in muscle filaments and to ubiquitinate actin (Kudryashova et al., 2005); recessive mutations in TRIM32 cause a myopathy in humans (Frosk et al., 2002) and mice (Kudryashova et al., 2009).”
Albor, A., & Kulesz-Martin, M. F. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20344 · Cited by 19
“Typically, ubiquitylated proteins are then targeted for proteosomal degradation; however in other cases, ubiquitylation regulates the activity of MOLECULAR CARCINOGENESIS 46:585–590 (2007) 2007 WILEY-LISS, INC. Abbreviations: LGMD2H, limb-girdle muscular dystrophy type 2H; SCC, squamous cell carcinoma; HNSCC, head and…”
BackgroundInfluentialMuscular dystrophy overview: genetics and diagnosis
Mathews, K. D. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(03)00065-3 · Cited by 19
Mansur, A., Joseph, R., Kim, E. S., Beltran, P. M. J., Udeshi, N. D., Pearce, C., Jiang, H., Iwase, R., Milev, M. P., Almousa, H. A., et al. (2022) · eLife · doi:10.7554/elife.81966 · Cited by 19
Nalini, A., Polavarapu, K., Sunitha, B., et al. (2015) · Neurology India · doi:10.4103/0028-3886.162048 · Cited by 18
Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1
Hirose, S., Nishizumi, H., & Sakano, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.212 · Cited by 21
TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stability
Bahnassawy, L., Perumal, T. M., González-Cano, L., Hillje, A., Taher, L., Makałowski, W., Suzuki, Y., Fuellen, G., del Sol, A., & Schwamborn, J. C. (2015) · Scientific Reports · doi:10.1038/srep13456 · Cited by 19
Novel TRIM32 mutation in sarcotubular myopathy.
Panicucci, C., Traverso, M., Baratto, S., et al. (2019) · PubMed · Cited by 17
TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases
Kumarasinghe, L., Xiong, L., García-Gimeno, M. A., Lazzari, E., Sanz, P., & Meroni, G. (2021) · Cells · doi:10.3390/cells10040820 · Cited by 17
“Proximal muscles of the arms and legs are the most affected and, although symptoms are highly variable, in severe forms of the disease, patients may require the use of a wheelchair [15,16].”
Pavlou, M. A. S., Colombo, N., Fuertes-Álvarez, S., Nicklas, S., González-Cano, L., Marín, M. C., Gonçalves, J. M., & Schwamborn, J. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9989-9 · Cited by 18
Johnson, K., Ridder, W. D., Töpf, A., Bértoli, M., Phillips, L. C., Jonghe, P. D., Baets, J., Deconinck, T., Stojanović, V. R., Perić, S., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318288 · Cited by 17
Sato, T. Z., Okumura, F., Iguchi, A., Ariga, T., & Hatakeyama, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.012 · Cited by 17
A Common Haplotype Associated with the Basque 2362AG-TCATCT Mutation in the Muscular Calpain-3 Gene
Cobo, A. M., Saenz, A., Poza, J. J., et al. (2004) · Human Biology · doi:10.1353/hub.2005.0002 · Cited by 16
Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
Jeong, S. Y., Choi, J. H., Kim, J., Woo, J. S., & Lee, E. H. (2023) · Cells · doi:10.3390/cells12162104 · Cited by 15
“Repeats of the conserved NHL motif are carried by proteins in various prokaryotic and eukaryotic cells [3,47].”
BackgroundInfluentialThe Growing Family of Limb-Girdle Muscular Dystrophies: Old and Newly Identified Members
Bastian, A. E., Mageriu, V., Micu, G. V., & Manole, E. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0002 · Cited by 14
Guan, Y., Liang, X., Li, W., Lin, W., Liang, G., Xie, H., Hou, Y., Hu, Y., & Shang, X. (2023) · Skeletal Muscle · doi:10.1186/s13395-023-00319-x · Cited by 16
“The TRIM32 gene encodes a protein of 653 amino acids [9].”
BackgroundLimb-Girdle Muscular Dystrophy-Associated Protein Diseases
Broglio, L., Tentorio, M., Cotelli, M. S., Mancuso, M., Vielmi, V., Gregorelli, V., Padovani, A., & Filosto, M. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181d35b39 · Cited by 16
“This phenotype is related to the homozygous Asp487Asn mutation, the one that causes sarcotubular myopathy.(114,115)”
BackgroundInfluentialBawa, S., Gameros, S., Baumann, K., Brooks, D. S., Kollhoff, J. A., Žółkiewski, M., Cecconi, A. D. R., Panini, N., Russo, M., Piccirillo, R., et al. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-07-0453 · Cited by 14
“The pathological alleles present in the NHL domains of LGMD2H patients vary in origin, consisting of point mutations (R394H, D487N), a single amino acid deletion (D588∆), frameshift deletions (A422fs, T520fs, L535fs, I590fs) and a stop codon (R613*; Slack and Ruvkun, 1998; Frosk et al., 2002; Saccone et al., 2008; Bor…”
BackgroundLimb-girdle Muscular Dystrophy in Childhood
Bönnemann, C. G. (2005) · Pediatric Annals · doi:10.3928/0090-4481-20050701-14 · Cited by 14
McClatchey, M. A., du Toit, Z. D., Vaughan, R., Whatley, S. D., Martins, S., Hegde, S., Naudé, J. T. W., Thomas, D. H., Griffiths, D. F., Clarke, A. J., et al. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.103972 · Cited by 15
“Examples include Charcot-Marie-Tooth disease type 2R (TRIM2) (Ylikallio et al., 2013), Opitz G/BBB syndrome (MID1/TRIM18) (Quaderi et al., 1997), autosomal recessive limb-girdle muscular dystrophy type 8 (TRIM32) (Frosk et al., 2002) and Mulibrey nanism (TRIM37) (Avela et al., 2000).”
BackgroundXie, Y., Cao, J., Gan, S., Xu, L.-D., Zhang, D., Qian, S., Xu, F., Ding, Q., Schoggins, J. W., & Fan, W. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012312 · Cited by 13
Amato, A. A., & Brooke, M. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50121-7 · Cited by 15
The Limb Girdle Muscular Dystrophies: Our Ever-Expanding Knowledge
Wicklund, M., & Mendell, J. R. (2003) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200309000-00003 · Cited by 13
Zelinski, T. A., Coghlan, G., Mauthe, J., & Triggs‐Raine, B. L. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.10.009 · Cited by 12
Laing, N. G., Sewry, C. A., & Lamont, P. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)86001-5 · Cited by 12
Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
Chaikuad, A., Zhubi, R., Tredup, C., & Knapp, S. (2022) · IUCrJ · doi:10.1107/s2052252522008582 · Cited by 13
García, J. L., & Castrillo, J. L. (2004) · Placenta · doi:10.1016/j.placenta.2003.10.020 · Cited by 11
“Also, some studies suggest that the gene(s) responsible for limb-girdle muscular dystrophy type 2H [22], lie(s) in this region of 9q.”
ResultLiewluck, T., Tracy, J. A., Sorenson, E. J., & Engel, A. G. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.09.010 · Cited by 13
de la Torre, C., Illa, I., Faulkner, G., Soria, L., Robles-Cedeño, R., Domínguez‐Perles, R., de Luna, N., & Gallardo, E. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800087 · Cited by 13
“Mutations in Trim 32 have been associated with limb girdle muscular dystrophy type 2H [36].”
BackgroundZhang, Z., Xiong, L., Lu, B.-T., Zhang, H.-X., Zhang, P., & Wang, T. (2017) · Cell Transplantation · doi:10.1177/0963689717716510 · Cited by 9
The Gentle Side of the UPS: Ubiquitin-Proteasome System and the Regulation of the Myogenic Program
Olguín, H. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.821839 · Cited by 9
“As an example, mutations in the gene coding for the RING- E3 ligase Tripartite motif-containing protein 32 (TRIM32) are associated with limb-girdle muscular dystrophy 2H (LGMD2H) and sarcotubular myopathy (STM) (Frosk et al., 2002; Johnson et al., 2019).”
BackgroundSarcotubular Myopathy Due to Novel TRIM32 Mutation in Association with Multiple Sclerosis
Marchuk, M., DOVBONOS, T. A., Makukh, H., Semeryak, O., & Sharhorodska, Y. (2021) · Brain Sciences · doi:10.3390/brainsci11081020 · Cited by 10
Zuscik, M. J., Rosier, R. N., & Schwarz, E. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11158 · Cited by 8
Triggs‐Raine, B. L., Dyck, T., Boycott, K. M., Innes, A. M., Ober, C., Parboosingh, J. S., Botkin, A., Greenberg, C. R., & Spriggs, E. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.206 · Cited by 11
Self-citationSalem, I. H., Kamoun, F. F., Louhichi, N., Rouis, S., Mziou, M., Fendri-Kriaa, N., Ayadi, F. M., Triki, C., & Fakhfakh, F. (2010) · Bioscience Reports · doi:10.1042/bsr20100026 · Cited by 7
Expression, purification, and characterization of the TRIM49 protein
Guimarães, D. S. P. S. F., & Gomes, M. D. (2017) · Protein Expression and Purification · doi:10.1016/j.pep.2017.10.014 · Cited by 8
Klinik und Genetik der Gliedergürteldystrophien
Finsterer, J. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1769-5 · Cited by 7
Myoneuropathic presentation of limb girdle muscular dystrophy R8 with a novel TRIM32 mutation
Chandrasekharan, S. V., Sundaram, S., Malaichamy, S., Poyuran, R., & Nair, S. S. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.06.003 · Cited by 7
Amato, A. A., & Brooke, M. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00104-3 · Cited by 7
Wan, T., Wang, Y., Wang, C., Wang, H., Li, X., & Li, Y. (2022) · Cell Biology International · doi:10.1002/cbin.11897 · Cited by 7
“Human TRIM32 is ubiquitously expressed in many tissues, including the brain, heart, pancreatic islet, liver, and skeletal muscle (Frosk et al., 2002).”
BackgroundTripartite motif-containing protein 32 regulates Ca2+ movement in skeletal muscle
Choi, J. H., Jeong, S. Y., Kim, J., Woo, J. S., & Lee, E. H. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00426.2022 · Cited by 5
Hereditary and Acquired Myopathies
Salih, M. A. M., & Kang, P. B. (2020) · Springer eBooks · doi:10.1007/978-3-319-43153-6_43 · Cited by 9
Candidate-gene testing for orphan limb-girdle muscular dystrophies.
Aurino, S., Piluso, G., Saccone, V., et al. (2008) · PubMed · Cited by 6
The Congenital And Limb-girdle Muscular Dystrophies
Bönnemann, C. G., & Kirschner, J. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch8 · Cited by 6
The TRIM-NHL RNA-binding protein MEI-P26 modulates the size of Drosophila Type I neuroblast lineages
Hu, Y., Yang, X., & Lipshitz, H. D. (2025) · Genetics · doi:10.1093/genetics/iyaf015 · Cited by 6
“…of vertebrate nervous systems differs from that of invertebrates, our data suggest that there are evolutionarily conserved aspects of the role of MEI-P26 and its close vertebrate homolog, TRIM32, which is associated with sev - eral inherited diseases (Frosk et al. 2002; Chiang et al. 2006).”
Wang, H., Song, Y., Zhang, C., Zhan, J., Zhang, R., & Wang, H. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.07.009 · Cited by 5
“1) [33] in the Sushi domain, which is the complement regulatory protein region that contains many complements and adhesion proteins [34] .”
BackgroundSingh, S. H., Ramachandra, N. B., & Nongthomba, U. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.01.008 · Cited by 5
Wei, X., Miao, J., Kang, Z., et al. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5288 · Cited by 5
“Mutations in the TRIM32 gene, which encodes a protein consisting of 653 amino acids residues, are often associated with STM and the limb-girdle muscular dystrophy R8 (LGMDR8, previously known as LGMD2H; MIM 254110) [1], two conditions that present as different severities of the same disease [2]; Bardet Biedl syndrome…”
BackgroundIdentification of two novel human genes, DIPLA1 and DIPAS, expressed in placenta tissue
García, J., & Castrillo, J.-L. (2004) · Gene · doi:10.1016/j.gene.2004.10.004 · Cited by 7
Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy
Shunchang, S., Fan, Q., Wu, H., Leturcq, F., Yongjian, S., Bingfeng, Z., Wen, Y., & Deburgrave, N. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.05.014 · Cited by 5
ten Dam, L., de Visser, M., Ginjaar, I. B., et al. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200585 · Cited by 4
“Genomic sequencing, MLPA and Southern blotting Genomic DNA was extracted from patients’ whole blood or muscle using standard procedures and screened for (likely) pathogenic variants in CAPN3 (NM 000070.2), DYSF (NM 003494.3), SGCG (NM 000231.2), SGCA (NM 000023.2), SGCB (NM 000232.4), SGCD (NM 000337.5), TRIM32 (NM 01…”
BackgroundInfluentialSevere childhood autosomal recessive muscular dystrophy, mental subnormality and chorea
Khadilkar, S., Menezes, K., Singh, R., et al. (2006) · Neurology India · doi:10.4103/0028-3886.27157 · Cited by 4
“Though no disease-associated mutations were detected in four sarcoglycan genes, these results do not exclude all known causes of SCARMD, as additional genes can be associated with the SCARMD phenotype.([5,10,11]) However, none of these conditions are known to have central nervous system abnormalities seen in our patie…”
Backgroundvan der Graaf, K., Jindrich, K., Mitchell, R., & White‐Cooper, H. (2020) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaa046 · Cited by 4
“…dystrophy 2H, are caused by mutations in genes encoding muscle structural proteins ( dystrophin and Trim32 , respectively) (Hoffman et al. 1987; Frosk et al. 2002), while others, like myotonic dystrophy, are caused by defects in RNA metabolism (reviewed in Wheeler and Thornton 2007; Meola and…”
BackgroundMuscular dystrophies presenting with proximal muscle weakness
Vainzof, M., & Bushby, K. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.015 · Cited by 6
Sárközy, A., Bushby, K. M. D., & Mercuri, E. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00134-8 · Cited by 4
Llansó, L., Ravenscroft, G., Aceituno, C., Gutiérrez, A., Parmar, J., Gallano, P., Caballero‐Ávila, M., Carbayo, Á., Vesperinas, A., Collet‐Vidiella, R., et al. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70000 · Cited by 4
Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases
Akyürek, E. E., Erba, M., Barba, F. D., Sandonà, D., & Sacchetto, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188832 · Cited by 4
Limb-girdle Muscular Dystrophies
Mohassel, P., & Bönnemann, C. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00034-2 · Cited by 8
Limb-Girdle Muscular Dystrophy
Liang, W., & Nishino, I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00092-9 · Cited by 3
Liang, X., Si, J., Xie, H., Guan, Y., Lin, W., Lin, Z., Zheng, G., Wei, X., Xiong, X., Zhuang, Z., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01971-8 · Cited by 2
“Previous research [6–8 , 26 ] on LGMD R8 and its causative causative gene TRIM32 had Firstly, by compiling data on genotypes and corresponding impaired mobility phenotype in the patients(Fig.”
Diagnosis of the Muscular Dystrophies
Leigh, B., Frances, J., Kathryn, N., Sandra, T., & Nigel, F. (2012) · InTech eBooks · doi:10.5772/32551 · Cited by 3
Metadata
- Authors
- Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K.
- Affiliations
- University of Manitoba (CA)
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Wrogemann, Klaus
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 70
- Issue
- 3
- Pages
- 663-672
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC447621
- OpenAlex
- W2024140773
- Semantic Scholar
- 2761196aa5154b43901a405f8b3d734bf576cfe7
- Cited by
- 261
- References
- 34
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 16 · 2012: 17
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4158 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- TRIM32, E3 ubiquitin ligase, autosomal recessive myopathy, haplotype mapping, candidate gene mapping, protein-protein interaction
- MeSH terms
- Tripartite Motif Proteins, Amino Acid Sequence, Animals, DNA Mutational Analysis, Ethnicity, Exons, Female, Genetic Testing, Haplotypes, Homozygote, Humans, Ligases, Male, Manitoba, Molecular Sequence Data, Muscular Dystrophies, Mutation, Pedigree, RNA, Messenger, Transcription Factors, Consensus Sequence, Sequence Alignment, Protein Structure, Tertiary, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.